These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9506356)

  • 1. Hyperviscosity syndrome in patients with ovarian carcinoma.
    von Tempelhoff GF; Heilmann L; Hommel G; Schneider D; Niemann F; Zoller H
    Cancer; 1998 Mar; 82(6):1104-11. PubMed ID: 9506356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood rheology during chemotherapy in patients with ovarian cancer.
    von Tempelhoff GF; Niemann F; Schneider DM; Kirkpatrick CJ; Hommel G; Heilmann L
    Thromb Res; 1998 Apr; 90(2):73-82. PubMed ID: 9684760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between blood rheology, thrombosis and cancer survival in patients with gynecologic malignancy.
    von Tempelhoff GF; Nieman F; Heilmann L; Hommel G
    Clin Hemorheol Microcirc; 2000; 22(2):107-30. PubMed ID: 10831062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood coagulation and thrombosis in patients with ovarian malignancy.
    von Tempelhoff GF; Dietrich M; Niemann F; Schneider D; Hommel G; Heilmann L
    Thromb Haemost; 1997 Mar; 77(3):456-61. PubMed ID: 9065993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of rheologic variables during postoperative high-dose brachytherapy for uterine cancer.
    von Tempelhoff GF; Heilmann L; Pollow K; Hommel G
    Clin Appl Thromb Hemost; 2004 Jul; 10(3):239-48. PubMed ID: 15247981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood rheology in deep venous thrombosis--relation to persistent and transient risk factors.
    Alt E; Banyai S; Banyai M; Koppensteiner R
    Thromb Res; 2002 Aug; 107(3-4):101-7. PubMed ID: 12431474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative low hematocrit is an adverse prognostic biomarker in ovarian cancer.
    Chen J; Li Y; Cui H
    Arch Gynecol Obstet; 2021 Mar; 303(3):767-775. PubMed ID: 33011886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rheologic results and their correlation to hemostatic changes in patients with moderate and severe preeclampsia: an observational cross-sectional study.
    Soliman AA; Csorba R; Yilmaz A; Tsikoaras P; von Tempelhoff GF
    Clin Hemorheol Microcirc; 2015; 59(1):1-15. PubMed ID: 23089882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rheological parameters in the umbilical cord blood in moderate and severe forms of preeclampsia.
    Csorba R; Yilmaz A; Tsikouras P; Wieg C; Teichmann A; von Tempelhoff GF
    Clin Hemorheol Microcirc; 2013 Jan; 55(4):391-401. PubMed ID: 24113499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of rheological variables in cancer.
    von Tempelhoff GF; Heilmann L; Hommel G; Pollow K
    Semin Thromb Hemost; 2003 Oct; 29(5):499-513. PubMed ID: 14631550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative plasma fibrinogen, platelet count and prognosis in epithelial ovarian cancer.
    Qiu J; Yu Y; Fu Y; Ye F; Xie X; Lu W
    J Obstet Gynaecol Res; 2012 Apr; 38(4):651-7. PubMed ID: 22413879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of pretreatment serum hemoglobin and survival in epithelial ovarian cancer.
    Obermair A; Petru E; Windbichler G; Peters-Engl C; Graf AH; Stummvoll W; Kaider A; Kurschel S; Kölbl H; Sevelda P
    Oncol Rep; 2000; 7(3):639-44. PubMed ID: 10767382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rheological, hemostaseological changes during immunetherapy for prevention of HELLP-syndrome in a patient with elevated phospholipid antibodies.
    von Tempelhoff GF; Tsikouras P; Rath W; Velten E; Csorba R
    Clin Hemorheol Microcirc; 2015; 60(1):123-31. PubMed ID: 25818156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood rheology at term in normal pregnancy and in patients with adverse outcome events.
    von Tempelhoff GF; Velten E; Yilmaz A; Hommel G; Heilmann L; Koscielny J
    Clin Hemorheol Microcirc; 2009; 42(2):127-39. PubMed ID: 19433886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide scavenging by cell-free hemoglobin may be a primary factor determining hypertension in polycythemic patients.
    Rusak T; Misztal T; Piszcz J; Tomasiak M
    Free Radic Res; 2014 Feb; 48(2):230-8. PubMed ID: 24180690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggregability and disaggregability of erythrocytes in women suffering from ovarian cancer: evidence for an increased disaggregation threshold.
    El Bouhmadi A; Laffargue F; Brun JF
    Clin Hemorheol Microcirc; 2000; 22(2):91-7. PubMed ID: 10831060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfusion utilization during adnexal or peritoneal cancer surgery: effects on symptomatic venous thromboembolism and survival.
    Abu-Rustum NR; Richard S; Wilton A; Lev G; Sonoda Y; Hensley ML; Gemignani M; Barakat RR; Chi DS
    Gynecol Oncol; 2005 Nov; 99(2):320-6. PubMed ID: 16061278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Preoperative Chemotherapy and Postoperative Complications in Patients Undergoing Surgery for Ovarian Cancer.
    Doo DW; Guy MS; Behbakht K; Davidson SA; Sheeder J; Guntupalli SR
    Ann Surg Oncol; 2016 Mar; 23(3):968-74. PubMed ID: 26542594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperviscosity in polycythemia vera and other red cell abnormalities.
    Kwaan HC; Wang J
    Semin Thromb Hemost; 2003 Oct; 29(5):451-8. PubMed ID: 14631544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
    Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
    Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.